Patent · US Expired

Combination preparation, containing cyclosporin A or FK506 or rapamycin and a xanthine derivative

US6046328A · kind A · utility

2Cited by

0References

1Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Martin Schönharting · Taunusstein, DE
Ulrich Gebert · Königstein, DE
Mark Waer · Heverlee, BE

Key dates

Filing date	Apr 3, 1997
Grant date	Apr 4, 2000
Priority date	—
Expiry date	Apr 3, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Xanthines of the formula I ##STR1## are useful in producing a superadditive increase in immunosuppressive action when combined with immunosuppressive compounds such as CysA or FK506.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.